ENTITY

Eco Animal Health Group (EAH LN)

20
Analysis
Health Care • United Kingdom
Eco Animal Health Group develops, registers, and markets pharmaceutical products for animals globally, specializing in veterinary pharmaceuticals, antibiotics, and vaccines for pigs and poultry. Its key product, Aivlosin®, is a macrolide antibiotic used to treat respiratory and enteric diseases in pigs and poultry. The company also offers generic drugs for parasitic and bacterial infections in various livestock. Headquartered in London, England, the company was founded in 1972.
more
•17 Sep 2026 22:00•Issuer-paid

ECO Animal Health - USDA approval for ECOVAXXIN®MS field safety

Eco Animal Health announces that the US Department of Agriculture, Centre for Veterinary Biologics (USDA-CVB) has confirmed that Eco Animal...

Logo
100 Views
Share
•13 Aug 2026 21:00•Issuer-paid

ECO Animal Health - Exclusive sheep vaccine licensing agreement

Late-stage vaccine opportunity. Eco Animal Health has signed a perpetual, exclusive licence agreement with Vaxinano for its sheep toxoplasmosis...

Logo
96 Views
Share
•15 Jul 2026 23:00•Issuer-paid

ECO Animal Health - FY26 results ahead of expectations

Strong FY26 delivery, ahead of expectations. Revenue increased 10%YoY to £87.5m (11.5% at constant currency), ahead of revised market...

Logo
126 Views
Share
•19 Mar 2026 17:01•Issuer-paid

ECO Animal Health - FY26 trading update: adj. EBITDA materially ahead

- Revenue +8% YoY; FY26E raised to £86.0m (+3%) - North America lifted to £23.0m (+7% YoY); Latin America to £16.7m (+2%, reversing an 18% FY25...

Logo
148 Views
Share
•11 Mar 2026 16:00•Issuer-paid

Eco Animal Health - ECOVAXXIN® MG receives US safety validation

Following the recent announcement of plans for commercialisation of ECOVAXXIN® MS, ECO Animal Health announces that the United States Department...

Logo
155 Views
Share
x